Benzidine mechanistic data and risk assessment: Species- and organ-specific metabolic activation

Pharmacology and Therapeutics

Volumn 71, Issue 1-2, 1996, Pages 107-126

  Whysner, John ^a   Verna, Lynne ^a   Williams, Gary M ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

aromatic amines; benzidine; DNA adducts; genotoxicity; neoplasia; risk assessment

Indexed keywords

BENZIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER RISK; CARCINOGENICITY; DNA ADDUCT; DOG; GENOTOXICITY; HAMSTER; LIVER CANCER; METABOLIC ACTIVATION; MOUSE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; RABBIT; RAT; REVIEW; RISK ASSESSMENT;

EID: 0029747155     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/0163-7258(96)00064-2     Document Type: Review

References (146)

1. Ames, B. N., Durston, W. E., Yamasaki, E. and Lee, F. D. (1973) Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc. Natl. Acad. Sci. USA 70: 2281-2285.
2. Anderson, D. and Styles, J. A. (1978) The bacterial mutation test. Br. J. Cancer 37: 924-930.
3. Anderson, R. S. and Döös, J. E. (1983) Activation of mammalian carcinogens to bacterial mutagens by microsomal enzymes from a pelecypod mollusk, Mercenaria mercenaria. Mutat. Res. 116: 247-256.
4. Anderson, R. S., Döös, J. E. and Rose, F. L. (1982) Differential ability of Ambystoma tigrinum hepatic microsomes to produce mutagenic metabolites from polycyclic aromatic hydrocarbons and aromatic amines. Cancer Lett. 16: 33-41.
5. Ashby, J., Paton, D., Lefevre, P. A. and Styles, J. A. (1982) Evaluation of two suggested methods of deactivating organic carcinogens by molecular modification. Carcinogenesis 3: 1277-1282.
6. Babu, S. R., Lakshmi, V. M., Hsu, F. F., Zenser, T. V. and Davis, B. B. (1992) Role of N-glucuronidation in benzidine-induced bladder cancer in dog. Carcinogenesis 13: 1235-1240.
7. Babu, S. R., Wongsurawat, V. J., Zenser, T. V. and Davis, B. B. (1993) Benzidine glucuronidation in dog liver. Carcinogenesis 14: 893-897.
8. Becker, F. F. (1982) Morphological classification of mouse liver tumors based on biological characteristics. Cancer Res. 42: 3918-3923.
9. Beije, B. (1987) Induction of unscheduled DNA synthesis in liver and micronucleus in bone marrow of rats exposed in vivo to the benzidine-derived azo dye, Direct Black 38. Mutat. Res. 187: 227-234.
10. Beland, F. A. and Kadlubar, F. F. (1985) Formation and persistence of arylamine DNA adducts in vivo. Environ. Health Perspect. 62: 19-30.
11. Beland, F. A. and Kadlubar, F. F. (1990) Metabolic activation and DNA adducts of aromatic amines and nitroaromatic hydrocarbons. In: Handbook of Experimental Pharmacology, pp. 267-325, Cooper, C. S. and Grover, P. L. (eds.) Springer-Verlag, Berlin.
12. Beland, F. A., Beranek, D. T., Dooley, K. L., Heflich, R. H. and Kadlubar, F. F. (1983) Arylamine-DNA adducts in vitro and in vivo: their role in bacterial mutagenesis and urinary bladder carcinogenesis. Environ. Health Perspect. 49: 125-134.
13. Bi, W., Hayes, R. B., Feng, P., Qi, Y., You, X., Zhen, J., Zhang, M., Qu, B., Fu, Z., Chen, M., Chien, H. T. C. and Blot, W. J. (1992) Mortality and incidence of bladder cancer in benzidine-exposed workers in China. Am. J. Indust. Med. 21: 481-489.
14. Boeniger, M. (1980) Technical Report: Carcinogenicity and Metabolism of Azo Dyes, Especially Those Derived from Benzidine. U.S. Department of Health and Human Services, National Institute for Occupational Safety and Health, Washington, DC.
15. Bolognesi, C., Cesarone, C. F. and Santi, L. (1981) Evaluation of DNA damage by alkaline elution technique after in vivo treatment with aromatic amines. Carcinogenesis 2: 265-268.
16. Bonser, G. M. (1959) Test for carcinogenic aromatic amines. J. Rep. Br. Emp. Cancer Camp. 37: 417-421.
17. Bonser, G. M., Clayson, D. B. and Jull, J. W. (1956) The induction of tumours of the subcutaneous tissues, liver and intestine in the mouse by certain dye-stuffs and their intermediates. Br. J. Cancer 10: 653-667.
18. Bos, R. P., van Doorn, R., Yih-van de Hurk, E., Van Gemert, P. J. L. and Henderson, P. T. (1982) Comparison of the mutagenicities of 4-aminobiphenyl and benzidine in the Salmonella/microsome, Salmonella/hepatocyte and host-mediated assays. Mutat. Res. 93: 317-325.
19. Bos, R. P., Neis, J. M., van Gemert, P. J. L. and Henderson, P. T. (1983) Mutagenicity testing with the Salmonella/hepatocyte and the Salmonella/microsome assays. Mutat. Res. 124: 103-112.
20. Boyland, E., Harris, J. and Horning, E. S. (1954) The induction of carcinoma of the bladder in rats with acetamidofluorene. Br. J. Cancer 8: 647-654.
21. Brouns, R. E., Poot, M., de Vrind, R., Hoek-Kon, T. V. and Henderson, P. T. (1979) Measurement of DNA-excision repair in suspensions of freshly isolated rat hepatocytes after exposure to some carcinogenic compounds. Its possible use in carcinogenicity screening. Mutat. Res. 64: 425-432.
22. Brouns, R. M. E., Bos, R. P., Van Doorn, R. and Henderson, P. T. (1982) Studies on the metabolic activaction of benzidine by isolated rat hepatocytes. Toxicology 23: 235-247.
23. Brown, J. P. and Dietrich, P. S. (1983) Mutagenicity of selected sulfonated azo dyes in the Salmonella/microsome assay: use of aerobic and anaerobic activation procedures. Mutat. Res. 116: 305-315.
24. Brown, J. P., Roehm, G. W. and Brown, R. J. (1978) Mutagenicity testing of certified food colors and related azo, xanthene and triphenylmethane dyes with the Salmonella/microsome system. Mutat. Res. 56: 249-271.
25. Büsser, M. T. and Lutz, W. K. (1987) Stimulation of DNA synthesis in rat and mouse liver by various tumor promoters. Carcinogenesis 8: 1433-1437.
26. Cartwright, R. A., Glashan, R. W., Rogers, H. J., Ahmad, R. A., Barham-Hall, D., Higgins, E. and Kahn, M. A. (1982) Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet ii: 842-845.
27. Carver, J. H., Salazar, E. P., Knize, M. G. and Wandres, D. L. (1981) Mutation induction at multiple gene loci in Chinese hamster ovary cells: genetic activity of 15 coded carcinogens and noncarcinogens. Prog. Mutat. Res. 1: 594-601.
28. Case, R. A. M., Hosker, M. E., McDonald, D. B. and Pearson, J. T. (1954) Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Br. J. Ind. Med. 11: 75-104.
29. Cesarone, C. F., Bolognesi, C. and Santi, L. (1982) Evaluation of damage to DNA after in vivo exposure to different classes of chemicals. Arch. Toxicol. 5 (Suppl.): 355-359.
30. Čihák, R. (1979) Evaluation of benzidine by the micronucleus test. Mutat. Res. 67: 383-384.
31. Clay, P. and Cross, M. F. (1990) Microwell mutation assays: evaluation of ethylmethanesulphonate, benzo[a]pyrene and benzidine using the tk locus in L5178Y mouse lymphoma cells. Mutagenesis 5: 45-54.
32. Commoner, B. (1976) Reliability of Bacterial Mutagenesis Techniques to Distinguish Carcinogenic and Noncarcinogenic Chemicals. US E.P.A. Report No. EPA-600/1-76-022, NTIS No. PB-259 934, Government Printing Office, Washington, DC.
33. Cotruvo, J. A., Simmon, V. F. and Spanggord, R. J. (1977) Investigation of mutagenic effects of products of ozonation reactions in water. Ann. NY Acad. Sci. 298: 124-140.
34. Crespi, C. L., Gonzalez, F. J., Steimel, D. T., Turner, T. R., Gelboin, H. V., Penman, B. W. and Langenbach, R. (1991) A metabolically competent human cell line expressing five CDNAS encoding procarcinogen-activating enzymes: application to mutagenicity testing. Chem. Res. Toxicol. 4: 566-572.
35. Crump, K. S., Guess, H. A. and Deal, K. L. (1977) Confidence intervals and test of hypotheses concerning dose-response relations inferred from animal carcinogenicity data. Biometrics 22: 437-451.
36. 1 chromosome assay. Prog. Mutat. Res. 1: 570-579.
37. Environmental Protection Agency (EPA) (1989) Exposure Factors Handhook. EPA/600/8-89/043.
38. Evans, D. A. P., Manley, K. A. and Mukusick, V. A. (1960) Genetic control of isoniazid metabolism in man. Br. Med. J. 2: 485-491.
39. Evans, E. L. and Mitchell, A. D. (1981) Effects of 20 coded chemicals on sister chromatid exchange frequencies in cultured Chinese hamster cells. Prog. Mutat. Res. 1: 538-550.
40. Ferretti, J. J., Lu, W. and Liu, M. B. (1977) Mutagenicity of benzidine and related compounds employed in the detection of hemoglobin. Am. J. Pathol. 67: 526-527.
41. Flammang, T. J., Yamazoe, Y., Benson, R. W., Roberts, D. W., Potter, D. W., Chu, D. Z. J., Lang, N. P. and Kadlubar, F. F. (1989) Arachidonic acid-dependent peroxidative activation of carcinogenic arylamines by extrahepatic human tissue microsomes. Cancer Res. 49: 1977-1982.
42. 3H/He mouse liver tumors and tumors induced with genotoxic and nongenotoxic hepatocarcinogens. Cancer Res. 50: 4014-4019.
43. Frederick, C. B., Weis, C. C., Flammang, T. J., Martin, C. N. and Kadlubar, F. F. (1985) Hepatic N-oxidation, acetyl-transfer and DNA-binding of the acetylated metabolites of the carcinogen, benzidine. Carcinogenesis 6: 959-965.
44. Frith, C. H. and Dooley, K. (1976) Brief communication: hepatic cytologic and neoplastic changes in mice given benzidine dihydrochloride. J. Natl. Cancer Inst. 56: 679-682.
45. Frymoyer, J. W. and Jacox, R. F. (1963a) Investigation of the genetic control of sulfadiazene and isoniazid metabolism in the rabbit. J. Lab. Clin. Med. 62: 891-904.
46. Frymoyer, J. W. and Jacox, R. F. (1963b) Studies of genetically controlled sulfadiazine acetylation in rabbit livers: possible identification of the heterozygous trait. J. Lab. Clin. Med. 62: 905-909.
47. Garner, R. C., Walpole, A. L. and Rose, F. L. (1975) Testing of some benzidine analogues for microsomal activation to bacterial mutagens. Cancer Lett. 1: 39-42.
48. Gaylor, D. W. and Kodell, R. L. (1980) Linear interpolation algorithm for low dose risk assessment of toxic substances. J. Environ. Pathol. Toxicol. 4: 305-312.
49. Genin, V. A. (1977) Formation of blastomogenic diphenylamino derivatives as a result of the metabolism of direct azo dyes. Vopr. Onkol. 23: 50-52.
50. Glowinski, I. B., Radtke, H. E. and Weber, W. W. (1978) Genetic variation in N-acetylation of carcinogenic arylamines by human and rabbit liver. Mol. Pharmacol. 14: 940-949.
51. Goldwater, L. J., Rosso, A. J. and Kleinfeld, M. (1965) Bladder tumors in a coal tar dye plant. Arch. Environ. Health 11: 814-817.
52. Gordon, G. R., Shafizadek, A. G. and Peters, J. H. (1973) Polymorphic acetylation of drugs in rabbits. Xenobiotica 3: 133-150.
53. Grady, M. K., Jacobson-Kram, D., Dearfield, K. L. and Williams, J. R. (1986) Induction of sister chromatid exchanges by benzidine in rat and human hepatoma cell lines and inhibition by indomethacin. Cell Biol. Toxicol. 2: 223-230.
54. Gregory, A. R. (1984) The carcinogenic potential of benzidine-based dyes. J. Environ. Pathol. Toxicol. Oncol. 5: 243-259.
55. Gregory, A. R., Elliott, J. and Kluge, P. (1981) Ames testing of Direct Black 38 parallels carcinogenicity testing. J. Appl. Toxicol. 1: 308-313.
56. Griswold, D. P., Casey, A. E., Weisburger, E. K. and Weisburger, J. H. (1968) The carcinogenicity of multiple intragastric doses of aromatic and heterocyclic nitro or amino derivatives in young female Sprague-Dawley rats. Cancer Res. 28: 924-933.
57. r) system. Prog. Mutat. Res. 1: 614-625.
58. Gupta, R. S. and Singh, B. (1982) Mutagenic responses of five independent genetic loci in CHO cells to a variety of mutagens. Development and characteristics of a mutagen screening system based on selection for multiple drug-resistant markers. Mutat. Res. 94: 449-466.
59. Hanke, J. and Krajewska, B. (1990) Acetylation phenotypes and bladder cancer. J. Occup. Med. 32: 917-918.
60. Hayes, R. B., Bi., W., Rothman, N., Broly, F., Caporaso, N., Feng, P., You, X., Yin, S., Woosley, R. L. and Meyer, U. A. (1993) N-Acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers. Carcinogenesis 14: 675-678.
61. Highman, B., Frith, C. H. and Littlefield, N. A. (1975) Alkaline phosphatase activity in hyperplastic and neoplastic urinary bladder epithelium of mice fed 2-acetylaminofluorene. J. Natl. Cancer Inst. 54: 257-261.
62. Iba, M. M. (1987) Comparative activation of 3,3′-dichlorobenzidine and related benzidines to mutagens in the Salmonella typhimurium assay by hepatic S9 and microsomes from rats pretreated with different inducers of cytochrome P-450. Mutat. Res. 182: 231-241.
63. International Agency for Research on Cancer (IARC) (1987) Benzidine. IARC Monogr. (Suppl. 7): 123-126.
64. Jotz, M. M. and Mitchell, A. D. (1981) Effects of 20 coded chemicals on the forward mutation frequency at the thymidine kinase locus in L5178Y mouse lymphoma cells. Prog. Mutat. Res. 1: 580-593.
65. Kadlubar, F. F., Yamazoe, Y., Lang, N. P., Chu, D. Z. J. and Beland, F. A. (1986) Carcinogen-DNA adduct formation as a predictor of metabolic activation pathways and reactive intermediates in benzidine carcinogenesis. Adv. Exp. Med. Biol. 197: 537-549.
66. Kennelly, J. C., Beland, F. A., Kadlubar, F. F. and Martin, C. N. (1984) Binding of N-acetylbenzidine and N,N'-diacetylbenzidine to hepatic DNA of rat and hamster in vivo and in vitro. Carcinogenesis 5: 407-412.
67. Kennelly, J. C., Clare, C. B., Campbell, J., Lane, M. P., Harrington, D. H., Cole, H. and Garner, R. C. (1990) The mutagenic activity of ethylmethanesulphonate, benzidine and benzo[a]pyrene at the hprt locus of wild-type L5178Y mouse lymphoma cells. Mutagenesis 5: 21-26.
68. Knaap, A. G. A. C., Goze, C. and Simons, J. W. I. M. (1981) Mutagenic activity of 7 coded samples in V79 Chinese hamster cells. Prog. Mutat. Res. 1: 608-613.
69. Kornbrust, D. J. and Barfknecht, T. R. (1984) Comparison of 7 azo dyes and their azo reduction products in the rat and hamster hepatocyte primary culture/DNA-repair assays. Mutat. Res. 136: 255-266.
70. Lakshmi, V. M., Mattammal, M. B., Spry, L. A., Kadlubar, F. F., Zenser, T. V. and Davis, B. B. (1990) Metabolism and disposition of benzidine in the dog. Carcinogenesis 11: 139-144.
71. Lavoie, E., Tulley, L., Fow, E. and Hoffmann, D. (1979) Mutagenicity of aminophenyl and nitrophenyl ethers, sulfides and disulfides. Mutat. Res. 67: 123-131.
72. Lazear, E. J. and Louie, S. C. (1977) Mutagenicity of some congeners of benzidine in the Salmonella typhimurium assay system. Cancer Lett. 4: 21-25.
73. Littlefield, N. A., Nelson, C. J. and Frith, C. H. (1983) Benzidine dihydrochloride: toxicological assessment in mice during chronic exposures. J. Toxicol. Environ. Health 12: 671-685.
74. Littlefield, N. A., Nelson, C. J. and Gaylor, D. W. (1984) Benzidine dihydrochloride: risk assessment. Fundam. Appl. Toxicol. 4: 69-80.
75. Lower, G. M., Jr. and Bryan, G. T. (1973) Enzymatic N-acetylation of carcinogenic aromatic amines by liver cytosol of species displaying different organ susceptibilities. Biochem. Pharmacol. 22: 1581-1588.
76. Lower, G. M., Jr., Nilsson, T., Nelson, C. E., Wolf, H., Gamsky, T. E. and Bryan, G. T. (1979) N-Acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environ. Health Perspect. 29:71-79.
77. Lynn, R. K., Garvie-Gould, C. T., Milam, D. F., Scott, K. F., Eastman, C. L., Ilias, A. M. and Rodgers, R. M. (1984) Disposition of the aromatic amine, benzidine, in the rat: characterization of mutagenic urinary and biliary metabolites. Toxicol. Appl. Pharmacol. 72: 1-14.
78. Martin, C. N. and Ekers, S. F. (1980) Studies on the macromolecular binding of benzidine. Carcinogenesis 1: 101-109.
79. Martin, C. N., McDermid, A. C. and Garner, R. C. (1978) Testing of known carcinogens and noncarcinogens for their ability to induce unscheduled DNA synthesis in HeLa cells. Cancer Res. 38: 2621-2627.
80. Martin, C. N., Beland, F. A., Roth, R. W. and Kadlubar, F. F. (1982) Covalent binding of benzidine and N-acetylbenzidine to DNA at the C-8 atom of deoxyguanosine in vivo and in vitro. Cancer Res. 42: 2678-2696.
81. Martire, G., Vricella, G., Perfumo, A. M. and DeLorenzo, F. (1981) Evaluation of the mutagenic activity of coded compounds in the Salmonella test. Prog. Mutat. Res. 1: 271-279.
82. Matsushima, T., Sugimura, T., Nagao, M., Yahagi, T., Shirai, A. and Sawamura, M. (1980) Factors modulating mutagenicity in microbial tests. In: Short Term Tests for Detecting Carcinogens, pp. 273-285, Norpoth, K. H. and Garner, R. C. (eds.) Springer, West Berlin.
83. McQueen, C. A. and Williams, G. M. (1983) The use of cells from rat, mouse, hamster, and rabbit in the hepatocyte primary culture/DNA-repair test. Ann. NY Acad. Sci. 1503: 119-130.
84. McQueen, C. A., Way, B. M. and Williams, G. M. (1987) Biotransformation of aromatic amines to DNA-damaging products by urinary bladder organ cultures. Carcinogenesis 8: 401-404.
85. Meigs, J. W., Brown, R. M. and Sciarini, L. J. (1951) A study of exposure to benzidme and substituted benzidine in a chemical plant. Arch. Ind. Hyg. Occup. Med. 4: 533-540.
86. Meigs, J. W., Marrett, L. D., Ulrich, F. U. and Flannery, J. T. (1986) Bladder tumor incidence among workers exposed to benzidine: a thirty-year follow up. J. Natl. Cancer Inst. 76: 1-8.
87. Mirsalis, J. and SRI International (1983) Evaluation of the Potential of Benzidine Dihydrochloride to Induce Unscheduled DNA Synthesis in Primary Rat Hepatocyte Cultures. Final Report Prepared for Environmental Protection Agency under Contract No. 68-02-3703, 25 January, SRI Project LUS 3447. Government Printing Office, Washington, DC.
88. Mirsalis, J. C., Tyson, C. K. and Butterworth, B. E. (1982) Detection of genotoxic carcinogens in the in vivo-in vitro hepatocyte DNA repair assay. Environ. Mutagen. 4: 553-562.
89. Morton, K. C., King, C. M. and Baetcke, K. P. (1979) Metabolism of benzidine to N-hydroxy-N,N'-diacetylbenzidine and subsequent nucleic acid binding and mutagenicity. Cancer Res. 39: 3107-3113.
90. Morton, K. C., Beland, F. A., Evans, F. E., Fullerton, N. F. and Kadlubar, F. F. (1980) Metabolic activation of N-hydroxy-N,N'-diacetylbenzidine by hepatic sulfotransferase. Cancer Res. 40: 751-757.
91. Morton, K. C., King, C. M., Vaught, J. B., Wang, C. Y., Lee, M. S. and Marnett, L. J. (1983) Prostaglandin H synthase-mediated reaction of carcinogenic arylamines with tRNA and homopolyribonucleotides. Biochem. Biophy. Res. Commun. 11: 96-103.
92. Nagao, M. and Takahashi, Y. (1981) Mutagenic activity of 42 coded compounds in the Salmonella/microsome assay. Prog. Mutat. Res. 1: 302-313.
93. Natarajan, A. T. and van Kesteren-van Leeuwen, A. C. (1981) Mutagenic activity of 20 coded compounds in chromosome aberrations/sister chromatid exchanges assay using Chinese hamster ovary (CHO) cells. Prog. Mutat. Res. 1: 551-559.
94. Neal, S. B. and Probst, G. S. (1983) Chemically-induced sister-chromatid exchange in vivo in bone marrow of Chinese hamsters. Mutat. Res. 113: 33-43.
95. Nelson, C. J., Baetcke, K. P., Frith, C. H., Kodell, R. L. and Schieferstein, G. (1982) The influence of sex, dose, time and cross on neoplasia in mice given benzidine dihydrochloride. Toxicol. Appl. Pharmacol. 64: 171-186.
96. +/- mouse lymphoma forward mutation assay using 42 chemicals. Mutat. Res. 125: 291-306.
97. Oglesby, L. A., Hix, C., Snow, L., Mac Nair, P., Seig, M. and Langerbach, R. (1983) Bovine bladder urothelial cell activation of carcinogens to metabolites mutagenic to Chinese hamster V79 cells and Salmonella typhimurium. Cancer Res. 43: 5194-5199.
98. Ohkawa, T., Fujinaga, T., Doi, J., Ebisuno, S., Takamatsu, M., Nakamura, J. and Kido, R. (1982) Clinical study on occupational uroepithelial cancer in Wakayama City. J. Urol. 128: 520-523.
99. Parodi, S., Taningher, M., Russo, P., Pala, M., Tamaro, M. and Monti-Bragadin, C. (1981) DNA-damaging activity in vivo and bacterial mutagenicity of sixteen aromatic amines and azo-derivatives, as related quantitatively to their carcinogenicity. Carcinogenesis 2: 1317-1326.
100. Parodi, S., Taningher, M., Boero, P. and Santi, L. (1982) Quantitative correlations amongst alkaline DNA fragmentation, DNA covalent binding, mutagenicity in the Ames test and carcinogenicity, for 21 compounds. Mutat. Res. 93: 1-24.
101. Parodi, S., Zunino, A., Ottaggio, L., De Ferrari, M. and Santi, L. (1983) Lack of correlation between the capability of inducing sister-chromatid exchanges in vivo and carcinogenic potency, for 16 aromatic amines and azo derivatives. Mutat. Res. 108: 225-238.
102. Perry, P. E. and Thomson, E. J. (1981) Evaluation of the sister chromatid exchange method in mammalian cells as a screening system for carcinogens. Prog. Mutat. Res. 1: 560-569.
103. Petzold, G. L. and Swenberg, J. A. (1978) Detection of DNA damage induced in vivo following exposure of rats to carcinogens. Cancer Res. 38: 1589-1594.
104. Phillips, D. H., Cross, M. F., Kennelly, J. C., Wilcox, P. and O'Donovan, M. R. (1990) Determination of benzidine-DNA adduct formation in CHO, HeLa, L5178Y, TK6 and V79 cells. Mutagenesis 5: 67-69.
105. Poirier, L. A., Miller, J. A. and Miller, E. C. (1963) The N-and ring-hydroxylation of 2-acetylaminofluorene and the failure to detect N-acetylation of 2-aminofluorene in the dog. Cancer Res. 23: 790-800.
106. Prival, M. J. and Mitchell, V. D. (1982) Analysis of a method for testing azo dyes for mutagenic activity in Salmonella typhimurium in the presence of flavin mononucleotide and hamster liver S9. Mutat. Res. 97: 103-116.
107. Prival, M. J., Bell, S. J., Mitchell, V. D., Peiperl, M. D. and Vaughan, V. L. (1984) Mutagenicity of benzidine and benzidine-congener dyes and selected monoazo dyes in a modified Salmonella assay. Mutat. Res. 136: 33-47.
108. Probst, G. S., McMahon, R. E., Hill, L. E., Thompson, C. Z., Epp, J. K. and Neal, S. B. (1981) Chemically-induced unscheduled DNA synthesis in primary rat hepatocyte cultures: a comparison with bacterial mutagenicity using 218 compounds. Environ. Mutagen. 3: 11-32.
109. Prokofjeva, O. G. (1971) Induction of hepatic tumors in mice by benzidine. Vopr. Onkol. 17: 61-64.
110. 1 mouse. Proc. Natl. Acad. Sci. USA 83: 33-37.
111. +/- mouse lymphoma mutagenicity assay using standardized and non-standardized protocols. Mutagenesis 5: 35-44.
112. Richold, M. and Jones, E. (1981) Mutagenic activity of 42 coded compounds in the Salmonella/microsome assay. Prog. Mutat. Res. 1: 314-322.
113. Rinde, E. and Troll, W. (1975) Metabolic reduction of benzidine azo dyes to benzidine in the Rhesus monkey. J. Natl. Cancer Inst. 55: 181-182.
114. Robens, J. F., Dill, G. S., Ward, J. M., Joiner, J. R., Griesemer, R. A. and Douglas, J. F. (1980) Thirteen-week subchronic toxicity studies of Direct Blue 6, Direct Black 38 and Direct Brown 95 dyes. Toxicol. Appl. Pharmacol. 54: 431-442.
115. Robinson, D. E. and Mitchell, A. D. (1981) Unscheduled DNA synthesis response of human fibroblasts, WI-38 cells, to 20 coded chemicals. Prog. Mutat. Res. 1: 517-527.
116. Rowland, I. and Severn, B. (1981) Mutagenicity of carcinogens and noncarcinogens in the Salmonella/microsome test. Prog. Mutat. Res. 1: 323-332.
117. Saffiotti, U., Cefis, F. and Montesano, R. (1967) Induction of bladder cancer in hamsters fed aromatic amines. In: Bladder Cancer: A Symposium, pp. 129-135, Lampe, K. F. (ed.) Aesculapius Publishing Co., Birmingham.
118. Salamone, M. F., Heddle, J. A. and Katz, M. (1981) Mutagenic activity of 41 compounds in the in vivo micronucleus assay. Prog. Mutat. Res. 1: 686-697.
119. Sciarini, L. J. and Meigs, J. W. (1958) The biotransformation of benzidine (4,4′-diaminobiphenyl), an industrial carcinogen in the dog. Arch. Ind. Health 18: 521-542.
120. Sciarini, L. J. and Meigs, J. W. (1961) The biotransformation of benzidine. II. studies in mouse and man. Arch. Environ. Health 2: 423-428.
121. Scott, T. S. (1952) The incidence of bladder tumours in a dye-stuffs factory. Br. J. Ind. Med. 9: 127-132.
122. Shimada, T., Iwasaki, M., Martin, M. V. and Guengerich, F. P. (1989) Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/ PSK1002. Cancer Res. 49: 3218-3228.
123. Simmon, V. F. and Shepherd, G. F. (1981) Mutagenic activity of 42 coded compounds in the Salmonella/microsome assay. Prog. Mutat. Res. 1: 333-342.
124. Sina, J. F., Bean, C. L., Dysart, G. R., Taylor, V. I. and Bradley, M. O. (1983) Evaluation of the alkaline elution/rat hepatocyte assay as a predictor of carcinogenic/mutagenic potential. Mutat. Res. 113: 357-391.
125. Smith, B. J., Curtis, J. F. and Eling, T. E. (1991) Bioactivation of xenobiotics by prostaglandin H synthase. Chem. Biol. Interact. 79: 245-264.
126. Spitz, S., Maguigan, W. H. and Dobriner, K. (1950) The carcinogenic action of benzidine. Cancer 3: 789-804.
127. Steinhoff, D. (1974) Starke cancerogene wirkung von benzidin lei weillichen Sprague-Dawley ratten. Naturwissenschaften 61: 276-277.
128. Tanaka, K. I., Marui, S. and Mii, T. (1980) Mutagenicity of extracts of urine from rats treated with aromatic amines. Mutat. Res. 79: 173-176.
129. Tanaka, K. I., Mii, T., Marui, S., Matsubara, I. and Igaki, H. (1982) Some aspects of metabolism and mutagenicity of o-tolidine and an o-tolidine-based azo dye. Ind. Health 20: 227-235.
130. Tang, T. and Friedman, M. A. (1977) Carcinogen activation by human liver enzymes in the Ames mutagenicity test. Mutat. Res. 46: 387-394.
131. The Merck Index (1989) 11th edn., Budavari, S., O'Neil, M. J., Smith, A. and Heckelman, P. E. (eds.) Merck & Co., Inc., Rabway.
132. Urwin, C., Richardson, J. C. and Palmer, A. K. (1976) An evaluation of the mutagenicity of the cutting oil preservative grotan BK. Mutat. Res. 40: 43-46.
133. U.S. Department of Health, Education and Welfare (1978) 13-Week Subchronic Toxicity Studies of Direct Blue 6, Direct Black 38, and Direct Brown 95 Dyes. DHEW Publication No. (NIH) 78-1358.
134. Venturini, S. and Tamaro, J. (1979) Mutagenicity of anthraquinone and azo dyes in Ames' Salmonella typhimurium test. Mutat. Res. 68: 307-312.
135. Vesselinovitch, S. D., Rao, K. V. N. and Mihailovich, N. (1975) Factors modulating benzidine carcinogenicity bioassay. Cancer Res. 35: 2814-2819.
136. Vigliani, E. C. and Barsotti, M. (1961) Environmental tumors of the bladder in some Italian dye-stuff factories. Med. Lav. 52: 241-250.
137. 1. Toxicol. Appl. Pharmacol. 100: 398-410.
138. Wang, C. Y., Zukowski, K., Yamada, H., Imaida, K. and Lee, M. S. (1990) Production of urothelial tumors in the heterotopic bladder of rat by benzidine derivatives. Cancer Res. 50: 2868-2871.
139. Weber, W. W. and Hein, D. W. (1985) N-acetylation pharmacogenetics. Phannacol. Rev. 37: 25-79.
140. Williams, G. M. (1978) Further improvements in the hepatocyte primary culture DNA repair test for carcinogens: detection of carcinogenic biphenyl derivatives. Cancer Lett. 4: 69-75.
141. Williams, G. M. (1981) Mammalian culture systems for the study of genetic effects of N-substituted aryl compounds. Natl. Cancer Inst. Monogr. 58: 237-242.
142. Williams, G. M. and Weisburger, J. H. (1991) Chemical carcinogenesis. In: Casarett and Doull's Toxicology The Basic Sciences of Poisons, 4th edn., pp. 127-200, Amdur, M. O., Doull, J. and Klaasen, C. D. (eds.) Pergamon Press, New York.
143. Wise, R. W., Zenser, T. V. and Davis, B. B. (1984) Characterization of benzidine diimine: a product of peroxidase metabolism of benzidine. Carcinogenesis 5: 1499-1503.
144. Wise, R. W., Zenser, T. V., Rice, J. R. and Davis, B. B. (1986) Peroxidative metabolism of benzidine by intact tissue: a prostaglandin H synthase-mediated process. Carcinogenesis 7: 111-115.
145. Yosbida, O., Harada, T., Kato, T. and Miyakawa, M. (1971) Bladder cancer in workers of the dyeing industry. Igaku No Ayumi 79: 421-422.
146. Zavon, M. R., Hoegg, U. and Bingham, E. (1973) Benzidine exposure as a cause of bladder tumors. Arch. Environ. Health 27: 1-7.